Sherlock
Boswellia for lungs and MC stabllizing
- Messages
- 1,287
- Location
- k8518704 USA
http://www.indiana.edu/~k562/articles/athero/Il-6 myokine Pederson 2006.pdf
TRENDS in Pharmacological Sciences Vol.28 No.4
Beneficial health effects of exercise – the role of IL-6 as a myokine
2007
http://www.ncbi.nlm.nih.gov/pubmed?db=PubMed&term=23897689
Compr Physiol.
Muscle as a secretory organ.
2013
http://www.nature.com/icb/journal/v92/n4/full/icb201416a.html
Immunology and Cell Biology
From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation
April 2014
TRENDS in Pharmacological Sciences Vol.28 No.4
Beneficial health effects of exercise – the role of IL-6 as a myokine
2007
Muscle-derived IL-6: the first myokine IL-6 is most often classified as a proinflammatory cytokine, although data also indicate that IL-6 and IL-6-regulated acute-phase proteins are anti-inflammatory and immunosuppressive and might negatively regulate the acute-phase response
http://www.ncbi.nlm.nih.gov/pubmed?db=PubMed&term=23897689
Compr Physiol.
Muscle as a secretory organ.
2013
Skeletal muscle is the largest organ in the body. Skeletal muscles are primarily characterized by their mechanical activity required for posture, movement, and breathing, which depends on muscle fiber contractions. However, skeletal muscle is not just a component in our locomotor system. Recent evidence has identified skeletal muscle as a secretory organ. We have suggested that cytokines and other peptides that are produced, expressed, and released by muscle fibers and exert either autocrine, paracrine, or endocrine effects should be classified as "myokines." The muscle secretome consists of several hundred secreted peptides. This finding provides a conceptual basis and a whole new paradigm for understanding how muscles communicate with other organs such as adipose tissue, liver, pancreas, bones, and brain.
http://www.nature.com/icb/journal/v92/n4/full/icb201416a.html
Immunology and Cell Biology
From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation
April 2014
The lack of physical activity and overnutrition in our modern lifestyle culminates in what we now experience as the current obesity and diabetes pandemic. Medical research performed over the past 20 years identified chronic low-grade inflammation as a mediator of these metabolic disorders. Hence, finding therapeutic strategies against this underlying inflammation and identifying molecules implicated in this process is of significant importance. Following the observation of an increased plasma concentration of interleukin-6 (IL-6) in obese patients, this protein, known predominantly as a pro-inflammatory cytokine, came into focus. In an attempt to clarify its importance, several studies implicated IL-6 as a co-inducer of the development of obesity-associated insulin resistance, which precedes the development of type 2 diabetes. However, the identification of IL-6 as a myokine, a protein produced and secreted by skeletal muscle to fulfil paracrine or endocrine roles in the insulin-sensitizing effects following exercise, provides a contrasting and hence paradoxical identity of this protein in the context of metabolism. We review here the literature considering the complex, pleiotropic role of IL-6 in the context of metabolism in health and disease.